Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Utilising CRISPR could reduce contamination in recombinant-protein drugs

europeanpharmaceuticalreviewMay 05, 2020

Tag: CRISPR , recombinant-protein drugs , CRISPR-Cas , Protein

PharmaSources Customer Service